+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Stone formation in prostatic urethra after potassium-titanyl-phosphate laser ablation of the prostate for benign prostatic hyperplasia



Stone formation in prostatic urethra after potassium-titanyl-phosphate laser ablation of the prostate for benign prostatic hyperplasia



Journal of Endourology 23(11): 1879-1881



We report three cases of stone formation at the prostatic urethra after 80 W potassium-titanyl-phosphate laser ablation of the prostate for benign prostatic hyperplasia. These complications occurred several months after the procedure. The diagnosis was made by ultrasonography, plain radiography of the kidneys, ureters, and bladder, and cystoscopy in patients who were being evaluated after presenting with irritative voiding symptoms. The patients were treated by cystolithotripsy and resection of the calcified prostatic tissue.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055929915

Download citation: RISBibTeXText

PMID: 19821697

DOI: 10.1089/end.2008.0596


Related references

Safety and efficacy of the potassium-titanyl-phosphate laser and photoselective vaporization of the prostate for benign prostatic hyperplasia. Reviews in Urology 8(Suppl. 3): S16-S23, 2006

The Efficacy and Safety of Photoselective Vaporization of the Prostate with a Potassium-titanyl-phosphate Laser for Symptomatic Benign Prostatic Hyperplasia according to Prostate Size: 2-Year Surgical Outcomes. Korean Journal of Urology 51(5): 330-336, 2010

High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 64(6): 1155-1159, 2004

Photoselective vaporization of the prostate (PVP) using 80 watt high power potassium-titanyl-phosphate (KTP) laser for benign prostatic hyperplasia: the first fifty-seven patients in Japan. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 97(7): 815-822, 2006

Experiences in the treatment of benign prostatic hyperplasia with high power potassium-titanyl-phosphate (KTP) laser. Wiadomosci Lekarskie 59(3-4): 196-198, 2006

High-power potassium-titanyl-phosphate laser fibres for endovaporization of benign prostatic hyperplasia: how much do they deteriorate during the procedure?. Bju International 107(12): 1938-1942, 2011

High-power potassium-titanyl-phosphate laser photoselective vaporization prostatectomy for symptomatic benign prostatic hyperplasia. Journal of Endourology 22(6): 1311-1314, 2008

Potassium-titanyl-phosphate (KTP)/lithium triboride (LBO) laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH): A systematic approach. 2007

Potassium-titanyl-phosphate laser photoselective vaporization for benign prostatic hyperplasia: 5-year follow-up from a district general hospital. Journal of Endourology 26(7): 878-883, 2012

High-power potassium-titanyl-phosphate or lithium triboride laser photoselective vaporization prostatectomy for benign prostatic hyperplasia: a systematic approach. Journal of Endourology 21(10): 1141-1144, 2007

Using laser to unobstruct the obstructed prostatic urethra due to benign prostatic hyperplasia: has transurethral resection of the prostate finally become history, or is it here to stay?. European Urology 60(4): 740-741, 2011

Estrogen receptors in the human male prostatic urethra and prostate in prostatic cancer and benign prostatic hyperplasia. Scandinavian Journal of Urology and Nephrology 33(4): 237-242, 1999

Outcome analysis of transurethral resection versus potassium titanyl phosphate-photo selective vaporization of the prostate for the treatment of benign prostatic hyperplasia; a randomized controlled trial with 4 years follow up. Turkish Journal of Urology 43(2): 176-182, 2017

Comment to the study: experiences in the treatment of benign prostatic hyperplasia with high power potassium-titanyl-phosphate (KTP). Wiadomosci Lekarskie 59(3-4): 292-292, 2006

Clinical outcome of potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy for benign prostate hyperplasia. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 92(4): 498-505, 2001